Fund announced today a total investment of approximately JPY 1.37 billion (USD 8.5 million1) in five R&D projects for the development of drugs for malaria and neglected tropical diseases (NTDs).2 ...
Medicine to treat babies and infants suffering from malaria has been approved for the first time and is expected to be rolled out in Africa within weeks. Malaria treatment for infants weighing less ...
Add Yahoo as a preferred source to see more of our stories on Google. Spread largely by mosquitos, Malaria causes a fever, headaches, confusion and muscle pains among other symptoms and can be fatal.
The first-ever treatment for malaria in young babies and infants has been approved. On Tuesday, Novartis announced it had received approval for the treatment, Coartem Baby (known as Riamet Baby in ...
NEW YORK — Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one involving a new class of drugs. Switzerland-based Novartis ...
Courtesy of the Nuffield Department of Medcine, University of Oxford When Nick White read the paper he was, by his own ...
Despite decades of efforts to combat it, malaria remains a major global health threat. According to the World Health ...
The Gauteng Department of Health has urged residents to remain vigilant and seek immediate medical attention if they ...
Researchers have developed a new microscopy method that uses a magnetic field and polarized light to provide quantitative ...
As Uganda joins the rest of the world to commemorate World Malaria Day 2026 on April 25 in Iganga District, the urgency of ...
The first malaria drug for newborn babies and those weighing less than 11 pounds has been approved by Swiss medical authorities in a move that could fill a treatment gap for some of those most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results